LY01005

· Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY01005, covering 2021-08-26 to 2023-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX® [Phase 3]